These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 785946)

  • 21. Preliminary results with passive enhancement in human kidney transplantation.
    Solheim BG; Flatmark A; Thorsby E
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
    Martins AC; Wren SF; Busch GJ; MacPherson SG; von Haefen U; Wilson RE
    AMB Rev Assoc Med Bras; 1975 Sep; 21(9):259-64. PubMed ID: 1103241
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
    J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
    Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE
    Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of pepsin-digested donor specific alloantibody to prolong renal allograft survival in dogs.
    Callender CO; Sutherland DE; Howard RJ; Toledo-Pereyra LH; Najarian JS
    Immunol Commun; 1974; 3(4):309-19. PubMed ID: 4618546
    [No Abstract]   [Full Text] [Related]  

  • 26. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral antibody in canine cardiac allograft rejection.
    Goldman BS; Shumak KH; Cartier J; Silver MD; Bigelow WG; Crookston JH
    Circulation; 1971 May; 43(5 Suppl):I115-9. PubMed ID: 4931285
    [No Abstract]   [Full Text] [Related]  

  • 29. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies of the adjuvant properties of homologous IgG split products: mode of action of F(ab')2 and related fragments.
    Kulberg AJ; Bartova LM; Evnin DN
    Immunology; 1978 Feb; 34(2):199-206. PubMed ID: 342398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical attempt to avoid hyperacute rejection by F (ab') 2 organ pretreatment.
    Ahlmén J; Gustafsson A; Claes G; Kaijser B; Svalander C; Gelin L
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):51-2. PubMed ID: 781817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.
    Soulillou JP; Carpenter CB; d'Apice AJ; Strom TB
    J Exp Med; 1976 Feb; 143(2):405-21. PubMed ID: 129499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses.
    Mhoyan A; Cramer DV; Baquerizo A; Shirwan H
    Transplantation; 1997 Dec; 64(12):1665-70. PubMed ID: 9422399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection.
    Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV
    J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE; Baldwin WM; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HLA antibody cytotoxicity by intravenous immunoglobulin G F(ab')2 dimers, monomers, and monovalent F(ab).
    Mahoney RJ; Breggia AE
    Hum Immunol; 1999 Jun; 60(6):492-9. PubMed ID: 10408798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the immune response to transplantation antigens. V. A comparison of the effects of antilymphocytic serum and enhancing alloantiserum on effector mechanisms of allograft rejection.
    Zola H
    Clin Exp Immunol; 1975 Feb; 19(2):367-76. PubMed ID: 1212805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.